CanSino Biologics, Inc. Class H (6185) Income Statement

Last quarter (Q3 2025), CanSino Biologics, Inc. Class H's total revenue was ¥338.98M, an increase of 28.58% from the same quarter last year. In Q3, CanSino Biologics, Inc. Class H's net income was ¥30.51M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.